NCT05710679View on ClinicalTrials.gov

Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer

NARecruitingINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

January 17, 2024

Primary Completion Date

April 30, 2029

Study Completion Date

July 31, 2031

Conditions
Locally Advanced Head and Neck Carcinoma
Interventions
BIOLOGICAL

Blood sample

"The intervention consist in a blood sample that will be taken twice :~* at the inclusion (before treatment)~* 3 months after the radiochemotherapy in case of incomplete response (PET-CT)"

Trial Locations (3)

63011

RECRUITING

Centre Jean PERRIN, Clermont-Ferrand

Unknown

RECRUITING

Hôpital de la Croix-Rousse, Lyon

RECRUITING

CHU de Saint-Étienne, Saint-Etienne

All Listed Sponsors
collaborator

GIRCI Auvergne Rhône-Alpes

UNKNOWN

lead

Centre Jean Perrin

OTHER